DADC
AMPH icon

D.A. Davidson & Co’s Amphastar Pharmaceuticals AMPH Stock Holding History

D.A. Davidson & Co’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,244
Closed -$417K – 1411
2024
Q4 		$417K Buy
+11,244
New +$514K ﹤0.01% 1083
2024
Q2 		– Sell
-21,651
Closed -$951K – 1368
2024
Q1 		$951K Sell
21,651
-4,973
-19% -$257K 0.01% 752
2023
Q4 		$1.65M Sell
26,624
-205
-0.8% -$10.8K 0.02% 555
2023
Q3 		$1.23M Sell
26,829
-3,058
-10% -$167K 0.01% 608
2023
Q2 		$1.72M Sell
29,887
-15,187
-34% -$673K 0.02% 523
2023
Q1 		$1.69M Sell
45,074
-3,837
-8% -$126K 0.02% 503
2022
Q4 		$1.37M Sell
48,911
-179
-0.4% -$5.2K 0.02% 537
2022
Q3 		$1.38M Sell
49,090
-1,249
-2% -$40.8K 0.02% 495
2022
Q2 		$1.75M Sell
50,339
-795
-2% -$28.4K 0.02% 453
2022
Q1 		$1.84M Buy
+51,134
New +$1.45M 0.02% 472
2017
Q3 		– Sell
-3,000
Closed -$53K – 1116
2017
Q2 		$53K Sell
3,000
-175
-6% -$2.77K ﹤0.01% 1512
2017
Q1 		$46K Sell
3,175
-5,800
-65% -$91.2K ﹤0.01% 1547
2016
Q4 		$165K Hold
8,975
– – ﹤0.01% 1079
2016
Q3 		$170K Hold
8,975
– – ﹤0.01% 1007
2016
Q2 		$144K Sell
8,975
-550
-6% -$7.76K ﹤0.01% 965
2016
Q1 		$114K Buy
9,525
+900
+10% +$10.6K ﹤0.01% 1070
2015
Q4 		$122K Buy
8,625
+8,175
+1,817% +$108K ﹤0.01% 1035
2015
Q3 		$5K Hold
450
– – ﹤0.01% 1993
2015
Q2 		$7K Buy
+450
New +$7.01K ﹤0.01% 1941

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.A. Davidson & Co's AMPH Position: Q1 2025 in Review

D.A. Davidson & Co sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 11,244 shares — an estimated $417K sold.

D.A. Davidson & Co first reported a position in AMPH in Q2 2015 and held it in 19 quarters. The position peaked at $1.84M in Q1 2022. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • D.A. Davidson & Co reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • D.A. Davidson & Co sold 11,244 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $417K.
  • D.A. Davidson & Co first reported a position in Amphastar Pharmaceuticals in Q2 2015 and held it in 19 quarters.
  • D.A. Davidson & Co's Amphastar Pharmaceuticals position peaked at $1.84M in Q1 2022.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on D.A. Davidson & Co's 13F filing for Q1 2025, filed 28 Apr 2025.